Cite
Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. V. 1-Aminocyclopentanecarboxylic acid (NSC-1026).
MLA
Bergsagel, D. E., et al. “Evaluation of New Chemotherapeutic Agents in the Treatment of Multiple Myeloma. V. 1-Aminocyclopentanecarboxylic Acid (NSC-1026).” Cancer Chemotherapy Reports, vol. 21, Aug. 1962, pp. 101–06. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=13867792&authtype=sso&custid=ns315887.
APA
Bergsagel, D. E., Ross, S. W., & Baker, D. T. (1962). Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. V. 1-Aminocyclopentanecarboxylic acid (NSC-1026). Cancer Chemotherapy Reports, 21, 101–106.
Chicago
Bergsagel, D E, S W Ross, and D T Baker. 1962. “Evaluation of New Chemotherapeutic Agents in the Treatment of Multiple Myeloma. V. 1-Aminocyclopentanecarboxylic Acid (NSC-1026).” Cancer Chemotherapy Reports 21 (August): 101–6. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=13867792&authtype=sso&custid=ns315887.